Clinical Trial Update: Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant arterial embolization chemotherapy combined with a PD-1 inhibitor for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Rectal Neoplasms

Drugs mentioned

• PD-1 inhibitor
• neoadjuvant arterial embolization chemotherapy

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Rectal Neoplasms | Phase 2 | Status: UNKNOWN